Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Big Is The Seizures Market Today And What Is Its Future Size?

The market size for seizures has experienced robust growth in the past few years. Its growth is projected to increase from $4.1 billion in 2024 to $4.34 billion in 2025, with a compound annual growth rate (CAGR) of 5.8%. The expansion during the historical period can be linked to factors such as the increasing occurrence of epilepsy and seizure disorders, the rise in awareness and diagnosis rates, amplified research and development related to neurological disorders, enhanced government and non-profit epilepsy awareness initiatives, and the increasing elderly population.

The market for seizures is projected to experience substantial growth in the coming years. It is projected to reach a value of $5.45 billion in 2029, with an expected compound annual growth rate (CAGR) of 5.9%. Factors contributing to this growth, expected over the forecast period, include a growing elderly population susceptible to neurological conditions, increasing investments in research and development for seizure treatments, a global rise in healthcare spending, increased demand for epilepsy medications, and an increase in seizure disorder cases. Key trends impacting the forecast period encompass advancements in seizure detection and monitoring systems, progress in drug approvals and reimbursement related to seizures, enhancements in genetic research for precision seizure therapies, the implementation of digital health solutions for remote seizure monitoring and progress in epilepsy medication.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23511&type=smp

Which Demand Drivers Are Strengthening The Seizures Market?

The escalating occurrence of traumatic brain injuries (TBI) is predicted to drive the seizures market’s expansion. TBI is due to harm inflicted on the brain by an abrupt external force, such as a hit, jerk, or a penetrating wound to the head. There has been an increase in the rates of traumatic brain injuries due to the mounting number of road crashes, where high-speed impacts and inattentive driving result in more severe cranial injuries. Seizures can act as an initial sign of traumatic brain injuries, allowing physicians to diagnose and address the underlying brain damage with better efficiency. For example, a report released by the South Dakota Department of Health (SDDOH), a government entity based in South Dakota, in October 2023 showed that South Dakota had the 9th highest age-adjusted TBI-related fatality rate at 26.4 per 100,000 in 2022. Additionally, the American Association of Neurological Surgeons, a US-based professional organization, estimated in April 2024 that around 1.7 to 3.8 million traumatic brain injuries occur in the US per annum. Therefore, the growing occurrence of traumatic brain injuries contributes to the seizures market’s growth.

Which Segment Accounts For The Largest Share In The Seizures Market?

The seizuresmarket covered in this report is segmented –

1) By Drug Type: First Generation Anti-Epileptics; Second Generation Anti-Epileptics; Third Generation Anti-Epileptics

2) By Route Of Administration: Oral; Parenteral; Topical

3) By Distribution Channel: Hospitals Pharmacies; Independent Pharmacies; Online Pharmacies

4) By End-User: Hospitals And Clinics; Ambulatory Surgical Centers; Homecare Settings; Other End-Users

Subsegments:

1) By First Generation Anti-Epileptics: Phenytoin; Carbamazepine; Valproate; Phenobarbital; Primidone; Ethosuximide

2) By Second Generation Anti-Epileptics: Lamotrigine; Levetiracetam; Topiramate; Oxcarbazepine; Zonisamide; Gabapentin; Pregabalin

3) By Third Generation Anti-Epileptics: Lacosamide; Perampanel; Brivaracetam; Eslicarbazepine; Cenobamate

What Strategic Shifts And Innovations Are Influencing The Seizures Market?

Leading businesses in the seizures market are pioneering new products such as buccal films to improve treatment availability and patient adherence. A buccal film is a slim strip that dissolves and is applied against the inner cheek lining (buccal mucosa), allowing the medication to be absorbed directly into the bloodstream. For instance, in December 2024, Aquestive Therapeutics Inc., a pharmaceutical company based in the US, was granted orphan drug exclusivity by the U.S. FDA for their product Libervant (diazepam) buccal film, designed for pediatric patients aged two to five suffering from seizure clusters. This innovative formulation provides a non-invasive, simple-to-use alternative to conventional diazepam delivery methods, ensuring quick absorption through the buccal mucosa for a quicker onset of action. Libervant, being the first and only orally administered diazepam film approved for this age bracket, aims to enhance caregiver convenience and boost patient adherence. This exclusivity further consolidates Aquestive’s standing in pushing forward oral film-based epilepsy treatments.

Which Companies Hold A Competitive Edge In The 1643 Market?

Major companies operating in the seizures market are Johnson & Johnson Service Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., UCB S.A., Eisai Co. Ltd., H. Lundbeck A/S, Zydus Lifesciences Limited, SK Biopharmaceuticals Co. Ltd., Neurocrine Biosciences Inc., Supernus Pharmaceuticals Inc., Taro Pharmaceutical Industries Ltd., Marinus Pharmaceuticals Inc., Eton Pharmaceuticals Inc., Sunovion Pharmaceuticals Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/seizures-global-market-report

Which Region Is Forecasted To Lead The Seizures Market In The Coming Years?

North America was the largest region in the seizures market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the seizures market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=23511&type=smp

Browse Through More Reports Similar to the Global Seizures Market 2025, By The Business Research Company

Grand Mal Seizure Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/grand-mal-seizure-treatment-global-market-report

Brain Tumor Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/brain-tumor-drugs-global-market-report

Brain And Neuroimaging Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/brain-and-neuroimaging-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model